See more : Tecnoglass Inc. (TGLS) Income Statement Analysis – Financial Results
Complete financial analysis of Themis Medicare Limited (THEMISMED.NS) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Themis Medicare Limited, a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
- Polyrocks Chemical Co., Ltd (688669.SS) Income Statement Analysis – Financial Results
- Apyx Medical Corporation (APYX) Income Statement Analysis – Financial Results
- Grape King Bio Ltd (1707.TW) Income Statement Analysis – Financial Results
- FINDEX Inc. (3649.T) Income Statement Analysis – Financial Results
- Reckon Limited (RKN.AX) Income Statement Analysis – Financial Results
Themis Medicare Limited (THEMISMED.NS)
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Website: https://www.themismedicare.com
About Themis Medicare Limited
Themis Medicare Limited, together with its subsidiaries, manufactures and sells pharmaceutical products in India and internationally. It offers active pharmaceutical ingredients and formulations for use in various therapeutic areas, including anti-infective, antimalarial, anti-tuberculosis, cardiology, health and nutrition, oncology, ophthalmology, and pain management. The company was formerly known as Themis Chemicals and changed its name to Themis Medicare Limited in 2001. Themis Medicare Limited was incorporated in 1969 and is headquartered in Mumbai, India.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 3.82B | 3.54B | 3.95B | 2.31B | 2.02B | 1.84B | 2.10B | 2.46B | 2.33B | 2.02B | 1.95B | 1.73B | 1.58B | 2.50B | 2.28B | 2.15B | 2.39B | 1.78B |
| Cost of Revenue | 1.40B | 1.18B | 1.52B | 805.33M | 648.71M | 695.23M | 730.06M | 830.14M | 873.52M | 923.51M | 862.37M | 816.57M | 1.46B | 2.27B | 1.96B | 2.08B | 2.07B | 1.53B |
| Gross Profit | 2.42B | 2.36B | 2.43B | 1.50B | 1.37B | 1.14B | 1.36B | 1.63B | 1.45B | 1.10B | 1.09B | 918.40M | 114.83M | 228.09M | 319.52M | 66.25M | 313.14M | 245.24M |
| Gross Profit Ratio | 63.39% | 66.59% | 61.48% | 65.09% | 67.82% | 62.17% | 65.15% | 66.23% | 62.48% | 54.25% | 55.79% | 52.93% | 7.28% | 9.11% | 13.99% | 3.09% | 13.12% | 13.81% |
| Research & Development | 127.94M | 142.54M | 136.38M | 84.97M | 34.32M | 45.85M | 52.84M | 51.38M | 35.05M | 26.64M | 16.60M | 20.20M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 845.80M | 93.45M | 99.22M | 66.85M | 44.58M | 61.87M | 62.25M | 59.81M | 40.19M | 329.21M | 23.87M | 27.91M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 152.07M | 170.30M | 260.78M | 149.21M | 81.36M | 132.15M | 145.17M | 111.06M | 150.52M | 31.78M | 100.58M | 76.46M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 997.86M | 263.75M | 360.00M | 216.06M | 125.95M | 194.02M | 207.42M | 170.87M | 190.70M | 360.99M | 525.81M | 455.08M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Expenses | 0.00 | 115.05M | 12.65M | 6.82M | 29.11M | 1.17M | 8.86M | 6.05M | 8.97M | 114.56M | 31.19M | 20.50M | 288.93M | 1.97M | 28.83M | 7.45M | 20.24M | 31.52M |
| Operating Expenses | 1.13B | 1.79B | 1.56B | 1.09B | 1.09B | 1.20B | 1.19B | 1.26B | 1.09B | 1.02B | 939.10M | 839.94M | 288.93M | 1.97M | 28.83M | 7.45M | 20.24M | 31.52M |
| Cost & Expenses | 2.51B | 2.97B | 3.08B | 1.90B | 1.74B | 1.89B | 1.92B | 2.09B | 1.96B | 1.94B | 1.80B | 1.66B | 1.75B | 2.28B | 1.99B | 2.09B | 2.09B | 1.56B |
| Interest Income | 8.39M | 5.47M | 6.06M | 4.12M | 3.04M | 2.44M | 4.98M | 5.27M | 3.27M | 2.60M | 1.28M | 4.31M | 1.09M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 93.77M | 95.64M | 65.37M | 109.66M | 110.72M | 104.07M | 104.27M | 96.18M | 107.95M | 125.98M | 156.29M | 152.78M | 158.70M | 103.07M | 83.71M | 152.70M | 94.69M | 79.48M |
| Depreciation & Amortization | 122.46M | 104.95M | 94.80M | 85.47M | 82.72M | 79.90M | 74.15M | 74.70M | 111.23M | 115.55M | 93.56M | 86.17M | 77.95M | 78.55M | 77.48M | 77.36M | 62.64M | 35.47M |
| EBITDA | 733.17M | 789.56M | 1.02B | 531.16M | 391.22M | 72.14M | 250.93M | 331.34M | 381.57M | 320.88M | 286.42M | 164.63M | -128.44M | 304.67M | 368.17M | 137.45M | 356.71M | 265.13M |
| EBITDA Ratio | 19.20% | 26.13% | 28.19% | 26.37% | 22.96% | 3.16% | 13.97% | 15.80% | 17.80% | 14.94% | 12.44% | 9.49% | -6.10% | 12.17% | 16.12% | 6.41% | 14.95% | 14.93% |
| Operating Income | 1.30B | 820.79M | 861.55M | 409.47M | 274.56M | -56.99M | 178.20M | 368.27M | 366.80M | 78.76M | 149.19M | 78.46M | -174.09M | 226.12M | 290.69M | 58.80M | 292.91M | 213.73M |
| Operating Income Ratio | 34.13% | 23.17% | 21.83% | 17.75% | 13.62% | -3.10% | 8.51% | 14.98% | 15.76% | 3.90% | 7.65% | 4.52% | -11.04% | 9.03% | 12.73% | 2.74% | 12.28% | 12.03% |
| Total Other Income/Expenses | -768.67M | -702.11M | -773.40M | -563.46M | -5.81M | -69.01M | -64.30M | -81.00M | -91.40M | -105.95M | -107.29M | -130.43M | -127.66M | -103.82M | -83.71M | -152.70M | -94.69M | -79.48M |
| Income Before Tax | 534.43M | 725.15M | 952.62M | 413.31M | 268.75M | -125.97M | 113.36M | 195.21M | 195.23M | 60.03M | 36.58M | -40.62M | -332.79M | 123.05M | 206.99M | -93.89M | 198.22M | 134.25M |
| Income Before Tax Ratio | 14.00% | 20.47% | 24.14% | 17.92% | 13.33% | -6.86% | 5.41% | 7.94% | 8.39% | 2.97% | 1.88% | -2.34% | -21.11% | 4.92% | 9.06% | -4.38% | 8.31% | 7.56% |
| Income Tax Expense | 99.20M | 156.14M | 223.81M | 56.28M | 20.93M | -18.37M | 1.02M | 6.80M | 12.58M | 17.71M | 13.12M | 7.11M | 5.06M | 20.74M | 558.00K | 17.54M | 16.43M | 26.62M |
| Net Income | 435.24M | 569.01M | 728.81M | 357.03M | 247.82M | -107.42M | 112.97M | 194.90M | 193.23M | 50.06M | 23.46M | -47.72M | -337.85M | 99.84M | 205.86M | -113.55M | 180.15M | 106.59M |
| Net Income Ratio | 11.40% | 16.06% | 18.47% | 15.48% | 12.29% | -5.85% | 5.39% | 7.93% | 8.30% | 2.48% | 1.20% | -2.75% | -21.43% | 3.99% | 9.01% | -5.29% | 7.55% | 6.00% |
| EPS | 4.73 | 6.18 | 7.92 | 3.89 | 2.70 | -1.17 | 12.28 | 17.66 | 19.12 | 7.34 | 3.19 | -5.93 | -41.97 | 14.16 | 25.57 | -14.10 | 22.38 | 13.24 |
| EPS Diluted | 4.72 | 6.17 | 7.91 | 3.88 | 2.70 | -1.17 | 12.28 | 17.66 | 18.96 | 7.24 | 3.05 | -5.93 | -41.97 | 14.16 | 25.57 | -14.10 | 22.38 | 13.24 |
| Weighted Avg Shares Out | 92.03M | 92.03M | 92.03M | 92.03M | 92.03M | 92.03M | 92.03M | 92.03M | 92.03M | 92.03M | 92.03M | 92.03M | 92.03M | 92.03M | 92.03M | 92.03M | 92.03M | 92.03M |
| Weighted Avg Shares Out (Dil) | 92.21M | 92.18M | 92.03M | 92.03M | 92.03M | 92.03M | 92.03M | 92.03M | 92.03M | 92.03M | 92.03M | 92.03M | 92.03M | 92.03M | 92.03M | 92.03M | 92.03M | 92.03M |
Source: https://incomestatements.info
Category: Stock Reports